Together we will beat cancer


Discovering the BRCA2 gene – 25 years on

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

Read More

Opinion: “There’s cause for optimism in 2021 and beyond”

COVID-19 changed so much of our plans, but it didn’t change everything. In this dark year, there were still pockets of light, writes our CEO Michelle Mitchell.

Read More

Cancer research in 2020: A spotlight on Manchester

2020 has certainly been tough, and no industry has been left untouched by the effects of the pandemic. And while the same undoubtedly goes for our work, we’ve once again been inspired by the resilience and determination of our researchers.

Read More

Opinion: ‘We can’t afford to stop now’

Last week, the UK Government announced what it would spend money on next year. Overall, the results were a mixed bag – but a step in the right direction, writes Michelle Mitchell.

Read More

Why the voices of people affected by cancer are critical to our work, now more than ever

Our network members are amazing, and we’ve done some brilliant work together, writes our director of information and involvement.

Read More

The long road to targeting the holy grail of the immune response

A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works.

Read More

What’s happened to cancer clinical trials during the COVID-19 pandemic?

As coronavirus cases continue to rise in the UK, we look at how cancer clinical trials have been affected by the pandemic.

Read More

We’re asking scientists to tackle 9 of the toughest challenges in cancer research

This entry is part 25 of 25 in the series Cancer Grand Challenges

We’ve partnered with the National Cancer Institute in the US (NCI) to stimulate even more innovative research collaborations through Cancer Grand Challenges.

Read More

The team of over 60 scientists investigating the age-old mystery of inflammation and cancer

This entry is part 24 of 25 in the series Cancer Grand Challenges

We spoke to 3 members of the global STORMing Cancer team about their work to solve the mystery of inflammation and cancer.

Read More

The changing landscape of children’s cancer treatment

We spoke to Professor Lou Chesler and Dr Lynley Marshall about the innovative studies that are aiming to make children’s cancer treatment more tailored.

Read More